154 related articles for article (PubMed ID: 15945588)
21. Fluphenazine (oral) versus atypical antipsychotics for schizophrenia.
Sampford JR; Sampson S; Li BG; Zhao S; Xia J; Furtado VA
Cochrane Database Syst Rev; 2016 Jul; 7(7):CD010832. PubMed ID: 27370402
[TBL] [Abstract][Full Text] [Related]
22. Behavioral and psychological symptoms of dementia (BPSD) in elderly demented subjects: is the long lasting use of atypical antipsychotic drugs useful and safe?
Angelini A; Bendini C; Neviani F; Neri M
Arch Gerontol Geriatr; 2007; 44 Suppl 1():35-43. PubMed ID: 17317431
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease.
Schneider LS; Tariot PN; Dagerman KS; Davis SM; Hsiao JK; Ismail MS; Lebowitz BD; Lyketsos CG; Ryan JM; Stroup TS; Sultzer DL; Weintraub D; Lieberman JA;
N Engl J Med; 2006 Oct; 355(15):1525-38. PubMed ID: 17035647
[TBL] [Abstract][Full Text] [Related]
24. Atypical antipsychotics for the treatment of dementia-related behaviors: an update.
Daiello LA
Med Health R I; 2007 Jun; 90(6):191-4. PubMed ID: 17633594
[TBL] [Abstract][Full Text] [Related]
25. Quetiapine versus other atypical antipsychotics for schizophrenia.
Asmal L; Flegar SJ; Wang J; Rummel-Kluge C; Komossa K; Leucht S
Cochrane Database Syst Rev; 2013 Nov; (11):CD006625. PubMed ID: 24249315
[TBL] [Abstract][Full Text] [Related]
26. Can risperidone and olanzapine in elderly patients with dementia and other mental disorders be discontinued?
Shah A
Int J Geriatr Psychiatry; 2006 Feb; 21(2):140-6. PubMed ID: 16416461
[TBL] [Abstract][Full Text] [Related]
27. A risk-benefit assessment of risperidone for the treatment of behavioural and psychological symptoms in dementia.
Zaudig M
Drug Saf; 2000 Sep; 23(3):183-95. PubMed ID: 11005702
[TBL] [Abstract][Full Text] [Related]
28. Safety profile assessment of risperidone and olanzapine in long-term care patients with dementia.
Martin H; Slyk MP; Deymann S; Cornacchione MJ
J Am Med Dir Assoc; 2003; 4(4):183-8. PubMed ID: 12837138
[TBL] [Abstract][Full Text] [Related]
29. Risperidone treatment in elderly patients with dementia: relative risk of cerebrovascular events versus other antipsychotics.
Finkel S; Kozma C; Long S; Greenspan A; Mahmoud R; Baser O; Engelhart L
Int Psychogeriatr; 2005 Dec; 17(4):617-29. PubMed ID: 16202186
[TBL] [Abstract][Full Text] [Related]
30. The relationship between antipsychotic treatment and quality of life for patients with dementia living in residential and nursing home care facilities.
Ballard CG; Margallo-Lana ML
J Clin Psychiatry; 2004; 65 Suppl 11():23-8. PubMed ID: 15264968
[TBL] [Abstract][Full Text] [Related]
31. Treatment changes among older patients with dementia treated with antipsychotics.
Kim HM; Chiang C; Weintraub D; Schneider LS; Kales H
Int J Geriatr Psychiatry; 2015 Dec; 30(12):1238-49. PubMed ID: 25759986
[TBL] [Abstract][Full Text] [Related]
32. Explicit review of risperidone long-acting injection prescribing practice.
Wheeler A; Vanderpyl J; Carswell C; Stojkovic M; Robinson E
J Clin Pharm Ther; 2011 Dec; 36(6):651-63. PubMed ID: 22023342
[TBL] [Abstract][Full Text] [Related]
33. Risperidone for the treatment of neuropsychiatric features in dementia.
Burns A; De Deyn PP
Drugs Aging; 2006; 23(11):887-96. PubMed ID: 17109567
[TBL] [Abstract][Full Text] [Related]
34. Risk of falls and fractures in older adults using atypical antipsychotic agents: a propensity score-adjusted, retrospective cohort study.
Chatterjee S; Chen H; Johnson ML; Aparasu RR
Am J Geriatr Pharmacother; 2012 Apr; 10(2):83-94. PubMed ID: 22306198
[TBL] [Abstract][Full Text] [Related]
35. Comparison of risperidone with olanzapine in elderly patients with dementia and psychosis.
Ellingrod VL; Schultz SK; Ekstam-Smith K; Kutscher E; Turvey C; Arndt S
Pharmacotherapy; 2002 Jan; 22(1):1-5. PubMed ID: 11794418
[TBL] [Abstract][Full Text] [Related]
36. An overview of systematic reviews of pharmacological and non-pharmacological interventions for the treatment of behavioral and psychological symptoms of dementia.
Dyer SM; Harrison SL; Laver K; Whitehead C; Crotty M
Int Psychogeriatr; 2018 Mar; 30(3):295-309. PubMed ID: 29143695
[TBL] [Abstract][Full Text] [Related]
37. [The use of antipsychotics in patients with dementia].
Forlenza OV; Cretaz E; Diniz BS
Braz J Psychiatry; 2008 Sep; 30(3):265-70. PubMed ID: 18833428
[TBL] [Abstract][Full Text] [Related]
38. [Prescription of psychotropic drugs in paediatry: approved indications and therapeutic perspectives].
Dumortier G; Welniarz B; Sauvebois C; Medjdoub H; Friche H; Siad N; Degrassat K
Encephale; 2005; 31(4 Pt 1):477-89. PubMed ID: 16389715
[TBL] [Abstract][Full Text] [Related]
39. Effect of olanzapine on cognition during treatment of behavioral and psychiatric symptoms in patients with dementia: a post-hoc analysis.
Deberdt WG; Siegal A; Ahl J; Meyers AL; Landbloom R
Int J Geriatr Psychiatry; 2008 Apr; 23(4):364-9. PubMed ID: 17708584
[TBL] [Abstract][Full Text] [Related]
40. Correlates of anticholinergic activity in patients with dementia and psychosis treated with risperidone or olanzapine.
Mulsant BH; Gharabawi GM; Bossie CA; Mao L; Martinez RA; Tune LE; Greenspan AJ; Bastean JN; Pollock BG
J Clin Psychiatry; 2004 Dec; 65(12):1708-14. PubMed ID: 15641877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
